XML 21 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 4,420 $ 1,338
Accounts receivable, net of allowance of $414 and $587, respectively 132,478 124,069
Inventory 89,686 81,761
Other current assets 6,538 5,989
Total current assets 233,122 213,157
Property, plant and equipment, net 3,323,830 2,301,982
Operating lease right-of-use assets 15,365 14,097
Goodwill 52,155 0
Intangible assets, net 98,271 30,182
Contract costs, net 37,764 37,739
Deferred tax assets 2,975 3,192
Other assets 52,855 47,733
Non-current assets of discontinued operations 7,868 7,868
Total assets 3,824,205 2,655,950
Current liabilities:    
Accounts payable, trade 57,567 61,026
Accrued liabilities 124,105 85,381
Deferred revenue 6,932 5,736
Total current liabilities 188,604 152,143
Long-term debt 2,198,376 1,584,869
Operating lease liabilities 12,415 12,271
Deferred tax liabilities 62,505 4,921
Other liabilities 30,906 22,857
Non-current liabilities of discontinued operations 7,868 7,868
Total liabilities 2,500,674 1,784,929
Commitments and contingencies (Note 17)
Equity:    
Preferred stock: $0.01 par value per share, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value per share, 250,000,000 shares authorized, 185,350,510 and 164,984,401 shares issued, respectively 1,854 1,650
Additional paid-in capital 3,880,936 3,470,576
Accumulated deficit (2,438,074) (2,499,931)
Treasury stock: 10,182,985 and 9,020,454 common shares, at cost, respectively (121,185) (101,274)
Total equity 1,323,531 871,021
Total liabilities and equity $ 3,824,205 $ 2,655,950